Home » MARK CERTIFICATION SMART EBV IN VITRO DIAGNOSTIC TEST FOR SMARTCYCLER PLATFORM CEPHEID LAUNCHES CE
MARK CERTIFICATION SMART EBV IN VITRO DIAGNOSTIC TEST FOR SMARTCYCLER PLATFORM CEPHEID LAUNCHES CE
May 15, 2006
Cepheid, a broad-based molecular diagnostics company, today announced the European release of the Smart EBV (Epstein-Barr Virus) Assay for clinical diagnostic use on the SmartCycler System. The EBV assay was released as a CE IVD Mark product under the European Directive on In Vitro Diagnostic Medical Devices. Smart EBV is intended for rapid detection and quantitation of EBV viral load. PR Newswire (http://www.prnewswire.com/cgi-bin/stories.pl?ACCT=104&STORY=/www/story/05-15-2006/0004361164&EDATE=)
KEYWORDS FDAnews Device Daily Bulletin
Upcoming Events
-
21Oct